Sort
23,748 grants matching “melanoma”
Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced Melanoma
$280,797Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA
BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGF
$280,788Anton Wellstein · Georgetown University · R01 · FY2008 · CA
BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGF
$280,788Anton Wellstein · Georgetown University · R01 · FY2009 · CA
BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGF
$280,788Anton Wellstein · Georgetown University · R01 · FY2010 · CA
BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGF
$280,788Anton Wellstein · Georgetown University · R01 · FY2007 · CA
Role of the mitochondrial RNA polymerase POLRMT in MYC function
$280,780Steven B McMahon · Thomas Jefferson University · R01 · FY2014 · CA
Senior Leadership
$280,753Russel E. Kaufman · Wistar Institute · P30 · FY2009 · CA
Photoacoustic detection, capture, and analysis of circulating melanoma cells
$280,721John A Viator · Duquesne University · R01 · FY2017 · CA
Photoacoustic detection, capture, and analysis of circulating melanoma cells
$280,721John A Viator · Duquesne University · R01 · FY2018 · CA
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
$280,670Donnele Daley · University Of Michigan At Ann Arbor · K08 · FY2023 · CA
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
$280,670Donnele Daley · University Of Michigan At Ann Arbor · K08 · FY2025 · CA
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
$280,670Donnele Daley · University Of Michigan At Ann Arbor · K08 · FY2024 · CA
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
$280,643Theresa A Guise · Indiana University Indianapolis · R01 · FY2010 · CA
Doxorubicin-Immunoconjugate Therapy of Non-Hodgkin's Lymphoma
$280,592Rhona N Stein · Ctr For Molecular Medicine/Immunology · R01 · FY2006 · CA
RETINOIC ACID RECEPTOR GAMMA SPECIFIC SIGNALING IN MELAN
$280,489Boston University Medical Campus · R01 · FY2002 · CA
Animal Model for Her-2/neu Specific TCR Gene Transfer
$280,412Michael I Nishimura · Medical University Of South Carolina · R01 · FY2006 · CA
Core 1: Administrative Core
$280,406Marcus W Bosenberg · Yale University · P50 · FY2022 · CA
GENETIC MODIFICATION OF HUMAN DENDRITIC CELLS FOR CANCER IMMUNITY
$280,350James W. Young · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Inhibitors in Src Signaling for Antitumor Therapy
$280,320Richard Jove · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA
Project 1
$280,289Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2024 · CA
PERTURBATION OF HYALURONAN FUNCTION IN CANCER
$280,254Tufts University Boston · R01 · FY2002 · CA
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA
$280,245John Wayne Cancer Institute · R01 · FY2001 · CA
Animal Model for Her-2/neu Specific TCR Gene Transfer
$280,188University Of Chicago · R01 · FY2005 · CA
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acids
$280,175Dipak Panigrahy · Boston Children'S Hospital · R01 · FY2012 · CA
ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES
$280,157University Of Arizona · R01 · FY2003 · CA